Project
GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for SOX17
Z-value: 0.54
Motif logo
Transcription factors associated with SOX17
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
SOX17
|
ENSG00000164736.5 | SRY-box transcription factor 17 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| SOX17 | hg19_v2_chr8_+_55370487_55370503 | 0.12 | 7.7e-02 | Click! |
Activity profile of SOX17 motif
Sorted Z-values of SOX17 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr2_-_89399845 | 24.74 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
| chr2_+_90139056 | 20.18 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
| chr19_+_58095501 | 18.82 |
ENST00000536878.2
ENST00000597850.1 ENST00000597219.1 ENST00000598689.1 ENST00000599456.1 ENST00000307468.4 |
ZIK1
|
zinc finger protein interacting with K protein 1 |
| chr19_-_10764509 | 17.61 |
ENST00000591501.1
|
ILF3-AS1
|
ILF3 antisense RNA 1 (head to head) |
| chrX_+_49216659 | 15.09 |
ENST00000415752.1
|
GAGE12I
|
G antigen 12I |
| chr6_-_32920794 | 14.76 |
ENST00000395305.3
ENST00000395303.3 ENST00000374843.4 ENST00000429234.1 |
HLA-DMA
XXbac-BPG181M17.5
|
major histocompatibility complex, class II, DM alpha Uncharacterized protein |
| chrX_+_49178536 | 14.46 |
ENST00000442437.2
|
GAGE12J
|
G antigen 12J |
| chr2_-_100939195 | 12.70 |
ENST00000393437.3
|
LONRF2
|
LON peptidase N-terminal domain and ring finger 2 |
| chr15_-_20193370 | 12.59 |
ENST00000558565.2
|
IGHV3OR15-7
|
immunoglobulin heavy variable 3/OR15-7 (pseudogene) |
| chrX_+_49235708 | 12.53 |
ENST00000381725.1
|
GAGE2B
|
G antigen 2B |
| chr17_-_5138099 | 12.28 |
ENST00000571800.1
ENST00000574081.1 ENST00000399600.4 ENST00000574297.1 |
SCIMP
|
SLP adaptor and CSK interacting membrane protein |
| chr15_-_47426320 | 12.16 |
ENST00000557832.1
|
FKSG62
|
FKSG62 |
| chr6_-_52710893 | 12.05 |
ENST00000284562.2
|
GSTA5
|
glutathione S-transferase alpha 5 |
| chr2_-_89278535 | 11.94 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
| chr19_+_6135646 | 11.89 |
ENST00000588304.1
ENST00000588485.1 ENST00000588722.1 ENST00000591403.1 ENST00000586696.1 ENST00000589401.1 ENST00000252669.5 |
ACSBG2
|
acyl-CoA synthetase bubblegum family member 2 |
| chr2_-_89417335 | 11.88 |
ENST00000490686.1
|
IGKV1-17
|
immunoglobulin kappa variable 1-17 |
| chrX_+_8432871 | 11.63 |
ENST00000381032.1
ENST00000453306.1 ENST00000444481.1 |
VCX3B
|
variable charge, X-linked 3B |
| chrY_+_2709906 | 11.44 |
ENST00000430575.1
|
RPS4Y1
|
ribosomal protein S4, Y-linked 1 |
| chrX_-_6453159 | 11.23 |
ENST00000381089.3
ENST00000398729.1 |
VCX3A
|
variable charge, X-linked 3A |
| chr3_-_123710199 | 10.92 |
ENST00000184183.4
|
ROPN1
|
rhophilin associated tail protein 1 |
| chr6_-_52628271 | 10.84 |
ENST00000493422.1
|
GSTA2
|
glutathione S-transferase alpha 2 |
| chr4_+_128554081 | 10.60 |
ENST00000335251.6
ENST00000296461.5 |
INTU
|
inturned planar cell polarity protein |
| chr3_+_125687987 | 10.33 |
ENST00000514116.1
ENST00000251776.4 ENST00000504401.1 ENST00000513830.1 ENST00000508088.1 |
ROPN1B
|
rhophilin associated tail protein 1B |
| chr12_-_71533055 | 10.04 |
ENST00000552128.1
|
TSPAN8
|
tetraspanin 8 |
| chr6_+_32605195 | 9.98 |
ENST00000374949.2
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1 |
| chr1_+_158901329 | 9.96 |
ENST00000368140.1
ENST00000368138.3 ENST00000392254.2 ENST00000392252.3 ENST00000368135.4 |
PYHIN1
|
pyrin and HIN domain family, member 1 |
| chrX_+_49197607 | 9.51 |
ENST00000402590.3
|
GAGE2E
|
G antigen 2E |
| chr1_-_48937821 | 9.17 |
ENST00000396199.3
|
SPATA6
|
spermatogenesis associated 6 |
| chr13_-_46756351 | 9.10 |
ENST00000323076.2
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
| chr5_+_49962772 | 9.06 |
ENST00000281631.5
ENST00000513738.1 ENST00000503665.1 ENST00000514067.2 ENST00000503046.1 |
PARP8
|
poly (ADP-ribose) polymerase family, member 8 |
| chr6_-_49755019 | 8.80 |
ENST00000304801.3
|
PGK2
|
phosphoglycerate kinase 2 |
| chr16_+_2867228 | 8.79 |
ENST00000005995.3
ENST00000574813.1 |
PRSS21
|
protease, serine, 21 (testisin) |
| chr14_+_77882741 | 8.77 |
ENST00000595520.1
|
FKSG61
|
FKSG61 |
| chr3_-_123710893 | 8.76 |
ENST00000467907.1
ENST00000459660.1 ENST00000495093.1 ENST00000460743.1 ENST00000405845.3 ENST00000484329.1 ENST00000479867.1 ENST00000496145.1 |
ROPN1
|
rhophilin associated tail protein 1 |
| chr12_+_69742121 | 8.72 |
ENST00000261267.2
ENST00000549690.1 ENST00000548839.1 |
LYZ
|
lysozyme |
| chr2_+_48844973 | 8.65 |
ENST00000403751.3
|
GTF2A1L
|
general transcription factor IIA, 1-like |
| chr12_+_25205568 | 8.59 |
ENST00000548766.1
ENST00000556887.1 |
LRMP
|
lymphoid-restricted membrane protein |
| chr12_+_25205666 | 8.43 |
ENST00000547044.1
|
LRMP
|
lymphoid-restricted membrane protein |
| chr12_-_11463353 | 8.40 |
ENST00000279575.1
ENST00000535904.1 ENST00000445719.2 |
PRB4
|
proline-rich protein BstNI subfamily 4 |
| chr16_-_70239683 | 8.35 |
ENST00000601706.1
|
AC009060.1
|
Uncharacterized protein |
| chr3_+_46412345 | 8.30 |
ENST00000292303.4
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene) |
| chrX_-_8139308 | 8.25 |
ENST00000317103.4
|
VCX2
|
variable charge, X-linked 2 |
| chr2_+_48844937 | 8.24 |
ENST00000448460.1
ENST00000437125.1 ENST00000430487.2 |
GTF2A1L
|
general transcription factor IIA, 1-like |
| chr11_+_125365110 | 8.14 |
ENST00000527818.1
|
AP000708.1
|
AP000708.1 |
| chr12_+_25205446 | 7.99 |
ENST00000557489.1
ENST00000354454.3 ENST00000536173.1 |
LRMP
|
lymphoid-restricted membrane protein |
| chr2_-_90538397 | 7.80 |
ENST00000443397.3
|
RP11-685N3.1
|
Uncharacterized protein |
| chr1_+_174844645 | 7.72 |
ENST00000486220.1
|
RABGAP1L
|
RAB GTPase activating protein 1-like |
| chr15_+_93749295 | 7.69 |
ENST00000599897.1
|
AC112693.2
|
AC112693.2 |
| chr15_-_28778117 | 7.61 |
ENST00000525590.2
ENST00000329523.6 |
GOLGA8G
|
golgin A8 family, member G |
| chr12_+_9822331 | 7.45 |
ENST00000545918.1
ENST00000543300.1 ENST00000261339.6 ENST00000466035.2 |
CLEC2D
|
C-type lectin domain family 2, member D |
| chr1_+_24969755 | 7.26 |
ENST00000447431.2
ENST00000374389.4 |
SRRM1
|
serine/arginine repetitive matrix 1 |
| chr6_-_52668605 | 7.23 |
ENST00000334575.5
|
GSTA1
|
glutathione S-transferase alpha 1 |
| chr19_-_58514129 | 7.22 |
ENST00000552184.1
ENST00000546715.1 ENST00000536132.1 ENST00000547828.1 ENST00000547121.1 ENST00000551380.1 |
ZNF606
|
zinc finger protein 606 |
| chrX_+_129473859 | 7.20 |
ENST00000424447.1
|
SLC25A14
|
solute carrier family 25 (mitochondrial carrier, brain), member 14 |
| chr2_-_157198860 | 7.18 |
ENST00000409572.1
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2 |
| chr15_+_101459420 | 7.13 |
ENST00000388948.3
ENST00000284395.5 ENST00000534045.1 ENST00000532029.2 |
LRRK1
|
leucine-rich repeat kinase 1 |
| chr12_-_11036844 | 7.13 |
ENST00000428168.2
|
PRH1
|
proline-rich protein HaeIII subfamily 1 |
| chr7_+_16828866 | 7.12 |
ENST00000597084.1
|
AC073333.1
|
Uncharacterized protein |
| chr1_-_48937838 | 7.11 |
ENST00000371847.3
|
SPATA6
|
spermatogenesis associated 6 |
| chrX_+_49363665 | 7.10 |
ENST00000381700.6
|
GAGE1
|
G antigen 1 |
| chrX_-_38186811 | 7.05 |
ENST00000318842.7
|
RPGR
|
retinitis pigmentosa GTPase regulator |
| chr11_-_85565906 | 7.02 |
ENST00000544076.1
|
AP000974.1
|
CDNA FLJ26432 fis, clone KDN01418; Uncharacterized protein |
| chr2_-_89327228 | 6.92 |
ENST00000483158.1
|
IGKV3-11
|
immunoglobulin kappa variable 3-11 |
| chr6_+_32605134 | 6.74 |
ENST00000343139.5
ENST00000395363.1 ENST00000496318.1 |
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1 |
| chr11_-_7695437 | 6.59 |
ENST00000533558.1
ENST00000527542.1 ENST00000531096.1 |
CYB5R2
|
cytochrome b5 reductase 2 |
| chr7_+_139025875 | 6.49 |
ENST00000297534.6
|
C7orf55
|
chromosome 7 open reading frame 55 |
| chr8_+_133931648 | 6.48 |
ENST00000519178.1
ENST00000542445.1 |
TG
|
thyroglobulin |
| chr2_+_90121477 | 6.47 |
ENST00000483379.1
|
IGKV1D-17
|
immunoglobulin kappa variable 1D-17 |
| chr2_+_71357744 | 6.42 |
ENST00000498451.2
|
MPHOSPH10
|
M-phase phosphoprotein 10 (U3 small nucleolar ribonucleoprotein) |
| chr16_-_15187865 | 6.37 |
ENST00000327307.7
|
RRN3
|
RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae) |
| chr10_+_76871353 | 6.27 |
ENST00000542569.1
|
SAMD8
|
sterile alpha motif domain containing 8 |
| chr19_+_48248779 | 6.25 |
ENST00000246802.5
|
GLTSCR2
|
glioma tumor suppressor candidate region gene 2 |
| chr6_+_126240442 | 6.14 |
ENST00000448104.1
ENST00000438495.1 ENST00000444128.1 |
NCOA7
|
nuclear receptor coactivator 7 |
| chr17_-_58042075 | 6.10 |
ENST00000305783.8
ENST00000589113.1 ENST00000442346.2 |
RNFT1
|
ring finger protein, transmembrane 1 |
| chr3_+_39093481 | 6.02 |
ENST00000302313.5
ENST00000544962.1 ENST00000396258.3 ENST00000418020.1 |
WDR48
|
WD repeat domain 48 |
| chr12_+_11081828 | 5.99 |
ENST00000381847.3
ENST00000396400.3 |
PRH2
|
proline-rich protein HaeIII subfamily 2 |
| chr8_+_27631903 | 5.97 |
ENST00000305188.8
|
ESCO2
|
establishment of sister chromatid cohesion N-acetyltransferase 2 |
| chr19_+_10764937 | 5.92 |
ENST00000449870.1
ENST00000318511.3 ENST00000420083.1 |
ILF3
|
interleukin enhancer binding factor 3, 90kDa |
| chr2_+_89184868 | 5.65 |
ENST00000390243.2
|
IGKV4-1
|
immunoglobulin kappa variable 4-1 |
| chr1_+_45805728 | 5.65 |
ENST00000539779.1
|
TOE1
|
target of EGR1, member 1 (nuclear) |
| chr6_+_142468361 | 5.64 |
ENST00000367630.4
|
VTA1
|
vesicle (multivesicular body) trafficking 1 |
| chr14_-_107219365 | 5.50 |
ENST00000424969.2
|
IGHV3-74
|
immunoglobulin heavy variable 3-74 |
| chr7_-_91808845 | 5.50 |
ENST00000343318.5
|
LRRD1
|
leucine-rich repeats and death domain containing 1 |
| chr19_+_15852203 | 5.49 |
ENST00000305892.1
|
OR10H3
|
olfactory receptor, family 10, subfamily H, member 3 |
| chr9_-_35650900 | 5.48 |
ENST00000259608.3
|
SIT1
|
signaling threshold regulating transmembrane adaptor 1 |
| chr9_-_115818951 | 5.45 |
ENST00000553380.1
ENST00000374227.3 |
ZFP37
|
ZFP37 zinc finger protein |
| chr8_-_66474884 | 5.43 |
ENST00000520902.1
|
CTD-3025N20.2
|
CTD-3025N20.2 |
| chr6_-_39902185 | 5.40 |
ENST00000373195.3
ENST00000308559.7 ENST00000373188.2 |
MOCS1
|
molybdenum cofactor synthesis 1 |
| chr9_+_100174232 | 5.29 |
ENST00000355295.4
|
TDRD7
|
tudor domain containing 7 |
| chr6_-_25042231 | 5.17 |
ENST00000510784.2
|
FAM65B
|
family with sequence similarity 65, member B |
| chr2_+_86668464 | 5.04 |
ENST00000409064.1
|
KDM3A
|
lysine (K)-specific demethylase 3A |
| chr5_-_10308125 | 4.93 |
ENST00000296658.3
|
CMBL
|
carboxymethylenebutenolidase homolog (Pseudomonas) |
| chr14_-_107283278 | 4.90 |
ENST00000390639.2
|
IGHV7-81
|
immunoglobulin heavy variable 7-81 (non-functional) |
| chr16_+_2867164 | 4.82 |
ENST00000455114.1
ENST00000450020.3 |
PRSS21
|
protease, serine, 21 (testisin) |
| chr15_-_81616446 | 4.78 |
ENST00000302824.6
|
STARD5
|
StAR-related lipid transfer (START) domain containing 5 |
| chr19_-_44809121 | 4.72 |
ENST00000591609.1
ENST00000589799.1 ENST00000291182.4 ENST00000589248.1 |
ZNF235
|
zinc finger protein 235 |
| chr5_-_132166579 | 4.64 |
ENST00000378679.3
|
SHROOM1
|
shroom family member 1 |
| chr22_-_32766972 | 4.62 |
ENST00000382084.4
ENST00000382086.2 |
RFPL3S
|
RFPL3 antisense |
| chr8_-_95220775 | 4.57 |
ENST00000441892.2
ENST00000521491.1 ENST00000027335.3 |
CDH17
|
cadherin 17, LI cadherin (liver-intestine) |
| chr7_-_29186008 | 4.53 |
ENST00000396276.3
ENST00000265394.5 |
CPVL
|
carboxypeptidase, vitellogenic-like |
| chr6_-_52705641 | 4.49 |
ENST00000370989.2
|
GSTA5
|
glutathione S-transferase alpha 5 |
| chr14_+_22293618 | 4.47 |
ENST00000390432.2
|
TRAV10
|
T cell receptor alpha variable 10 |
| chr6_-_45345597 | 4.44 |
ENST00000371460.1
ENST00000371459.1 |
SUPT3H
|
suppressor of Ty 3 homolog (S. cerevisiae) |
| chr3_-_105588231 | 4.44 |
ENST00000545639.1
ENST00000394027.3 ENST00000438603.1 ENST00000447441.1 ENST00000443752.1 |
CBLB
|
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
| chr7_-_102257139 | 4.43 |
ENST00000521076.1
ENST00000462172.1 ENST00000522801.1 ENST00000449970.2 ENST00000262940.7 |
RASA4
|
RAS p21 protein activator 4 |
| chr19_-_19887185 | 4.41 |
ENST00000590092.1
ENST00000589910.1 ENST00000589508.1 ENST00000586645.1 ENST00000586816.1 ENST00000588223.1 ENST00000586885.1 |
LINC00663
|
long intergenic non-protein coding RNA 663 |
| chr14_-_107013465 | 4.40 |
ENST00000390625.2
|
IGHV3-49
|
immunoglobulin heavy variable 3-49 |
| chr1_+_171217622 | 4.39 |
ENST00000433267.1
ENST00000367750.3 |
FMO1
|
flavin containing monooxygenase 1 |
| chr2_+_103035102 | 4.25 |
ENST00000264260.2
|
IL18RAP
|
interleukin 18 receptor accessory protein |
| chr10_-_27389392 | 4.25 |
ENST00000376087.4
|
ANKRD26
|
ankyrin repeat domain 26 |
| chr20_-_43883197 | 4.20 |
ENST00000338380.2
|
SLPI
|
secretory leukocyte peptidase inhibitor |
| chr19_+_10765003 | 4.15 |
ENST00000407004.3
ENST00000589998.1 ENST00000589600.1 |
ILF3
|
interleukin enhancer binding factor 3, 90kDa |
| chr17_+_41132564 | 4.07 |
ENST00000361677.1
ENST00000589705.1 |
RUNDC1
|
RUN domain containing 1 |
| chr15_+_34310428 | 4.02 |
ENST00000557872.1
|
CHRM5
|
cholinergic receptor, muscarinic 5 |
| chr14_-_106518922 | 3.98 |
ENST00000390598.2
|
IGHV3-7
|
immunoglobulin heavy variable 3-7 |
| chr17_+_57297807 | 3.95 |
ENST00000284116.4
ENST00000581140.1 ENST00000581276.1 |
GDPD1
|
glycerophosphodiester phosphodiesterase domain containing 1 |
| chr2_-_158300556 | 3.95 |
ENST00000264192.3
|
CYTIP
|
cytohesin 1 interacting protein |
| chr1_+_13641973 | 3.87 |
ENST00000330087.5
|
PRAMEF15
|
PRAME family member 15 |
| chrY_-_19992098 | 3.86 |
ENST00000544303.1
ENST00000382867.3 |
CDY2B
|
chromodomain protein, Y-linked, 2B |
| chr3_+_111260954 | 3.85 |
ENST00000283285.5
|
CD96
|
CD96 molecule |
| chr1_+_22333943 | 3.84 |
ENST00000400271.2
|
CELA3A
|
chymotrypsin-like elastase family, member 3A |
| chr11_-_116708302 | 3.83 |
ENST00000375320.1
ENST00000359492.2 ENST00000375329.2 ENST00000375323.1 |
APOA1
|
apolipoprotein A-I |
| chr19_+_3933085 | 3.82 |
ENST00000168977.2
ENST00000599576.1 |
NMRK2
|
nicotinamide riboside kinase 2 |
| chr12_-_96794143 | 3.82 |
ENST00000543119.2
|
CDK17
|
cyclin-dependent kinase 17 |
| chr3_-_164875850 | 3.70 |
ENST00000472120.1
|
RP11-747D18.1
|
RP11-747D18.1 |
| chr6_+_27107053 | 3.70 |
ENST00000354348.2
|
HIST1H4I
|
histone cluster 1, H4i |
| chr6_-_152958521 | 3.69 |
ENST00000367255.5
ENST00000265368.4 ENST00000448038.1 ENST00000341594.5 |
SYNE1
|
spectrin repeat containing, nuclear envelope 1 |
| chr4_+_71063641 | 3.63 |
ENST00000514097.1
|
ODAM
|
odontogenic, ameloblast asssociated |
| chr4_+_155665123 | 3.63 |
ENST00000336356.3
|
LRAT
|
lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase) |
| chr10_-_91295304 | 3.63 |
ENST00000341233.4
ENST00000371790.4 |
SLC16A12
|
solute carrier family 16, member 12 |
| chr2_+_231090433 | 3.55 |
ENST00000486687.2
ENST00000350136.5 ENST00000392045.3 ENST00000417495.3 ENST00000343805.6 ENST00000420434.3 |
SP140
|
SP140 nuclear body protein |
| chr4_+_156588249 | 3.50 |
ENST00000393832.3
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
| chr4_+_2794750 | 3.49 |
ENST00000452765.2
ENST00000389838.2 |
SH3BP2
|
SH3-domain binding protein 2 |
| chr14_-_106610852 | 3.47 |
ENST00000390603.2
|
IGHV3-15
|
immunoglobulin heavy variable 3-15 |
| chr1_-_160492994 | 3.37 |
ENST00000368055.1
ENST00000368057.3 ENST00000368059.3 |
SLAMF6
|
SLAM family member 6 |
| chr9_-_115819039 | 3.34 |
ENST00000555206.1
|
ZFP37
|
ZFP37 zinc finger protein |
| chr4_-_170897045 | 3.33 |
ENST00000508313.1
|
RP11-205M3.3
|
RP11-205M3.3 |
| chr1_-_45805667 | 3.33 |
ENST00000488731.2
ENST00000435155.1 |
MUTYH
|
mutY homolog |
| chr16_+_33629600 | 3.32 |
ENST00000562905.2
|
IGHV3OR16-13
|
immunoglobulin heavy variable 3/OR16-13 (non-functional) |
| chr22_+_32754139 | 3.31 |
ENST00000382088.3
|
RFPL3
|
ret finger protein-like 3 |
| chr3_+_111260856 | 3.29 |
ENST00000352690.4
|
CD96
|
CD96 molecule |
| chr6_+_136172820 | 3.28 |
ENST00000308191.6
|
PDE7B
|
phosphodiesterase 7B |
| chr18_+_5238055 | 3.25 |
ENST00000582363.1
ENST00000582008.1 ENST00000580082.1 |
LINC00667
|
long intergenic non-protein coding RNA 667 |
| chr1_-_45805607 | 3.23 |
ENST00000372104.1
ENST00000448481.1 ENST00000483127.1 ENST00000528013.2 ENST00000456914.2 |
MUTYH
|
mutY homolog |
| chrY_+_20137667 | 3.21 |
ENST00000250838.4
ENST00000426790.1 |
CDY2A
|
chromodomain protein, Y-linked, 2A |
| chr18_-_24283586 | 3.20 |
ENST00000579458.1
|
U3
|
Small nucleolar RNA U3 |
| chr11_-_59950622 | 3.17 |
ENST00000323961.3
ENST00000412309.2 |
MS4A6A
|
membrane-spanning 4-domains, subfamily A, member 6A |
| chr1_-_12946025 | 3.15 |
ENST00000235349.5
|
PRAMEF4
|
PRAME family member 4 |
| chr3_-_45838011 | 3.08 |
ENST00000358525.4
ENST00000413781.1 |
SLC6A20
|
solute carrier family 6 (proline IMINO transporter), member 20 |
| chr3_+_98451275 | 3.01 |
ENST00000265261.6
ENST00000497008.1 |
ST3GAL6
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 6 |
| chr16_+_28770025 | 3.00 |
ENST00000435324.2
|
NPIPB9
|
nuclear pore complex interacting protein family, member B9 |
| chr20_+_61448376 | 3.00 |
ENST00000343916.3
|
COL9A3
|
collagen, type IX, alpha 3 |
| chr10_-_72362515 | 2.97 |
ENST00000373209.2
ENST00000441259.1 |
PRF1
|
perforin 1 (pore forming protein) |
| chr1_+_158801095 | 2.95 |
ENST00000368141.4
|
MNDA
|
myeloid cell nuclear differentiation antigen |
| chr13_+_25338290 | 2.95 |
ENST00000255324.5
ENST00000381921.1 ENST00000255325.6 |
RNF17
|
ring finger protein 17 |
| chr2_+_113816215 | 2.95 |
ENST00000346807.3
|
IL36RN
|
interleukin 36 receptor antagonist |
| chr3_-_58200398 | 2.94 |
ENST00000318316.3
ENST00000460422.1 ENST00000483681.1 |
DNASE1L3
|
deoxyribonuclease I-like 3 |
| chr5_+_54398463 | 2.93 |
ENST00000274306.6
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) |
| chr19_+_7011509 | 2.90 |
ENST00000377296.3
|
AC025278.1
|
Uncharacterized protein |
| chr6_+_28109703 | 2.90 |
ENST00000457389.2
ENST00000330236.6 |
ZKSCAN8
|
zinc finger with KRAB and SCAN domains 8 |
| chr12_-_498620 | 2.88 |
ENST00000399788.2
ENST00000382815.4 |
KDM5A
|
lysine (K)-specific demethylase 5A |
| chrY_+_27768264 | 2.84 |
ENST00000361963.2
ENST00000306609.4 |
CDY1
|
chromodomain protein, Y-linked, 1 |
| chr22_+_32753854 | 2.82 |
ENST00000249007.4
|
RFPL3
|
ret finger protein-like 3 |
| chr19_-_48753104 | 2.81 |
ENST00000447740.2
|
CARD8
|
caspase recruitment domain family, member 8 |
| chr4_-_100212132 | 2.79 |
ENST00000209668.2
|
ADH1A
|
alcohol dehydrogenase 1A (class I), alpha polypeptide |
| chr4_+_170581213 | 2.77 |
ENST00000507875.1
|
CLCN3
|
chloride channel, voltage-sensitive 3 |
| chr16_+_71560023 | 2.76 |
ENST00000572450.1
|
CHST4
|
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 4 |
| chr1_+_45805342 | 2.76 |
ENST00000372090.5
|
TOE1
|
target of EGR1, member 1 (nuclear) |
| chr6_-_119256311 | 2.69 |
ENST00000316316.6
|
MCM9
|
minichromosome maintenance complex component 9 |
| chr17_-_55038375 | 2.68 |
ENST00000240316.4
|
COIL
|
coilin |
| chr19_+_34745442 | 2.67 |
ENST00000299505.6
ENST00000588470.1 ENST00000589583.1 ENST00000588338.2 |
KIAA0355
|
KIAA0355 |
| chr19_-_19843900 | 2.59 |
ENST00000344099.3
|
ZNF14
|
zinc finger protein 14 |
| chr2_+_157330081 | 2.56 |
ENST00000409674.1
|
GPD2
|
glycerol-3-phosphate dehydrogenase 2 (mitochondrial) |
| chr12_+_52668394 | 2.55 |
ENST00000423955.2
|
KRT86
|
keratin 86 |
| chr15_-_45815005 | 2.55 |
ENST00000261867.4
|
SLC30A4
|
solute carrier family 30 (zinc transporter), member 4 |
| chr8_-_7309887 | 2.44 |
ENST00000458665.1
ENST00000528168.1 |
SPAG11B
|
sperm associated antigen 11B |
| chr7_-_115608304 | 2.43 |
ENST00000457268.1
|
TFEC
|
transcription factor EC |
| chr4_-_122791583 | 2.40 |
ENST00000506636.1
ENST00000264499.4 |
BBS7
|
Bardet-Biedl syndrome 7 |
| chr1_+_20959943 | 2.38 |
ENST00000321556.4
|
PINK1
|
PTEN induced putative kinase 1 |
| chr6_+_84569359 | 2.35 |
ENST00000369681.5
ENST00000369679.4 |
CYB5R4
|
cytochrome b5 reductase 4 |
| chr19_-_21776784 | 2.31 |
ENST00000594927.1
|
RP11-678G14.4
|
RP11-678G14.4 |
| chr7_+_95115210 | 2.29 |
ENST00000428113.1
ENST00000325885.5 |
ASB4
|
ankyrin repeat and SOCS box containing 4 |
| chr1_+_156589051 | 2.27 |
ENST00000255039.1
|
HAPLN2
|
hyaluronan and proteoglycan link protein 2 |
| chr19_-_48752812 | 2.27 |
ENST00000359009.4
|
CARD8
|
caspase recruitment domain family, member 8 |
| chr1_+_13359819 | 2.23 |
ENST00000376168.1
|
PRAMEF5
|
PRAME family member 5 |
| chr12_+_32260085 | 2.23 |
ENST00000548411.1
ENST00000281474.5 ENST00000551086.1 |
BICD1
|
bicaudal D homolog 1 (Drosophila) |
| chr10_-_95209 | 2.22 |
ENST00000332708.5
ENST00000309812.4 |
TUBB8
|
tubulin, beta 8 class VIII |
| chr19_-_45909585 | 2.21 |
ENST00000593226.1
ENST00000418234.2 |
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like |
| chr15_-_33360085 | 2.18 |
ENST00000334528.9
|
FMN1
|
formin 1 |
| chr16_-_71523236 | 2.16 |
ENST00000288177.5
ENST00000569072.1 |
ZNF19
|
zinc finger protein 19 |
| chr1_-_13007420 | 2.14 |
ENST00000376189.1
|
PRAMEF6
|
PRAME family member 6 |
| chr5_+_135468516 | 2.11 |
ENST00000507118.1
ENST00000511116.1 ENST00000545279.1 ENST00000545620.1 |
SMAD5
|
SMAD family member 5 |
| chr6_-_42690312 | 2.11 |
ENST00000230381.5
|
PRPH2
|
peripherin 2 (retinal degeneration, slow) |
| chr1_+_171283331 | 2.08 |
ENST00000367749.3
|
FMO4
|
flavin containing monooxygenase 4 |
| chr2_+_33661382 | 2.06 |
ENST00000402538.3
|
RASGRP3
|
RAS guanyl releasing protein 3 (calcium and DAG-regulated) |
| chr17_-_39041479 | 2.05 |
ENST00000167588.3
|
KRT20
|
keratin 20 |
| chr9_-_100935043 | 2.01 |
ENST00000343933.5
|
CORO2A
|
coronin, actin binding protein, 2A |
| chr8_+_39442097 | 2.00 |
ENST00000265707.5
ENST00000379866.1 ENST00000520772.1 ENST00000541111.1 |
ADAM18
|
ADAM metallopeptidase domain 18 |
| chr5_-_41213607 | 1.99 |
ENST00000337836.5
ENST00000433294.1 |
C6
|
complement component 6 |
| chr12_-_7655329 | 1.96 |
ENST00000541972.1
|
CD163
|
CD163 molecule |
Network of associatons between targets according to the STRING database.
First level regulatory network of SOX17
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.7 | 14.8 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 2.4 | 7.2 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 2.4 | 7.1 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
| 1.7 | 8.7 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 1.7 | 5.0 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
| 1.6 | 4.7 | GO:0030451 | regulation of complement activation, alternative pathway(GO:0030451) negative regulation of complement activation, alternative pathway(GO:0045957) |
| 1.2 | 8.3 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 1.1 | 4.6 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
| 1.0 | 26.9 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 1.0 | 3.8 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
| 0.9 | 6.6 | GO:0045007 | depurination(GO:0045007) |
| 0.9 | 6.4 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.9 | 3.6 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.8 | 4.0 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.8 | 2.4 | GO:0036482 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
| 0.8 | 6.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.8 | 6.0 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
| 0.7 | 2.2 | GO:0072092 | ureteric bud invasion(GO:0072092) |
| 0.7 | 106.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.7 | 6.5 | GO:0015705 | iodide transport(GO:0015705) |
| 0.7 | 2.9 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
| 0.7 | 4.8 | GO:0015824 | proline transport(GO:0015824) |
| 0.7 | 5.4 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.6 | 10.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.6 | 5.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.6 | 1.8 | GO:0019605 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
| 0.6 | 2.9 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
| 0.6 | 3.5 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.6 | 9.1 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.6 | 5.1 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.6 | 7.2 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
| 0.6 | 2.8 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
| 0.5 | 2.6 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 0.5 | 2.5 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.5 | 1.5 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.5 | 11.9 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.5 | 1.5 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.5 | 1.8 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.5 | 2.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
| 0.4 | 2.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.4 | 2.2 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
| 0.4 | 4.8 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.4 | 5.6 | GO:1904896 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.4 | 1.2 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.4 | 1.6 | GO:0035627 | ceramide transport(GO:0035627) |
| 0.4 | 3.1 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.4 | 6.1 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.4 | 4.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.4 | 3.7 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.4 | 1.1 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.4 | 2.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 0.3 | 3.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.3 | 0.9 | GO:0051552 | flavone metabolic process(GO:0051552) |
| 0.3 | 2.8 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.3 | 2.1 | GO:0060041 | retina development in camera-type eye(GO:0060041) |
| 0.3 | 2.9 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.3 | 5.5 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.3 | 2.8 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 0.3 | 1.6 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.3 | 2.6 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.3 | 7.1 | GO:0036035 | osteoclast development(GO:0036035) |
| 0.2 | 3.0 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
| 0.2 | 8.8 | GO:0030317 | sperm motility(GO:0030317) |
| 0.2 | 5.7 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
| 0.2 | 0.6 | GO:1902896 | terminal web assembly(GO:1902896) |
| 0.2 | 1.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.2 | 1.7 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.2 | 23.5 | GO:0007338 | single fertilization(GO:0007338) |
| 0.2 | 3.4 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
| 0.2 | 14.2 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.2 | 5.3 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.2 | 1.5 | GO:0015980 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) energy reserve metabolic process(GO:0006112) energy derivation by oxidation of organic compounds(GO:0015980) glucan metabolic process(GO:0044042) |
| 0.2 | 2.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
| 0.2 | 0.9 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.2 | 14.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.2 | 9.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.2 | 4.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.2 | 0.5 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.2 | 1.4 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
| 0.2 | 2.9 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 0.1 | 1.0 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.1 | 5.5 | GO:0043029 | T cell homeostasis(GO:0043029) |
| 0.1 | 0.9 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.1 | 10.8 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 0.1 | 11.4 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.1 | 16.7 | GO:0031295 | T cell costimulation(GO:0031295) |
| 0.1 | 0.7 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
| 0.1 | 7.1 | GO:0042073 | intraciliary transport(GO:0042073) |
| 0.1 | 2.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 | 0.4 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.1 | 13.2 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.1 | 13.0 | GO:0007127 | meiosis I(GO:0007127) |
| 0.1 | 1.5 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.1 | 1.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.1 | 1.3 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.1 | 9.5 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.1 | 5.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.1 | 3.6 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
| 0.1 | 3.6 | GO:0072337 | modified amino acid transport(GO:0072337) |
| 0.1 | 2.2 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 0.1 | 0.9 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.1 | 0.5 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) regulation of release of cytochrome c from mitochondria(GO:0090199) positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 | 1.3 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.1 | 2.0 | GO:0045109 | intermediate filament organization(GO:0045109) |
| 0.1 | 0.5 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.1 | 5.7 | GO:0009060 | aerobic respiration(GO:0009060) |
| 0.1 | 4.7 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
| 0.1 | 0.6 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
| 0.1 | 0.9 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
| 0.1 | 1.2 | GO:0042737 | drug catabolic process(GO:0042737) |
| 0.1 | 3.3 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.1 | 4.4 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
| 0.1 | 0.2 | GO:0071676 | negative regulation of mononuclear cell migration(GO:0071676) |
| 0.1 | 16.9 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.1 | 1.9 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.1 | 7.3 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.1 | 2.7 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
| 0.1 | 1.1 | GO:0030539 | male genitalia development(GO:0030539) |
| 0.1 | 7.3 | GO:0031124 | mRNA 3'-end processing(GO:0031124) |
| 0.0 | 1.0 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
| 0.0 | 3.5 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.0 | 1.2 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.0 | 0.3 | GO:0006293 | nucleotide-excision repair, preincision complex stabilization(GO:0006293) nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.0 | 2.2 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.0 | 1.0 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
| 0.0 | 1.4 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.0 | 4.0 | GO:0042439 | ethanolamine-containing compound metabolic process(GO:0042439) |
| 0.0 | 0.2 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.0 | 2.0 | GO:0035556 | intracellular signal transduction(GO:0035556) |
| 0.0 | 1.0 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
| 0.0 | 0.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.0 | 2.4 | GO:0008585 | female gonad development(GO:0008585) |
| 0.0 | 6.0 | GO:0006473 | protein acetylation(GO:0006473) |
| 0.0 | 1.0 | GO:0006897 | endocytosis(GO:0006897) |
| 0.0 | 0.3 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.0 | 1.5 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.0 | 0.0 | GO:0002086 | diaphragm contraction(GO:0002086) |
| 0.0 | 0.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.0 | 0.7 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
| 0.0 | 0.8 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
| 0.0 | 0.5 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.0 | 0.6 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
| 0.0 | 0.8 | GO:0007292 | female gamete generation(GO:0007292) |
| 0.0 | 0.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.0 | 0.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.0 | 0.9 | GO:0007049 | cell cycle(GO:0007049) |
| 0.0 | 0.6 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 0.0 | 1.5 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.0 | 0.5 | GO:0006749 | glutathione metabolic process(GO:0006749) |
| 0.0 | 2.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.1 | 16.3 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 2.1 | 16.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 1.8 | 5.4 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 1.5 | 31.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 1.3 | 3.8 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 1.2 | 12.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.8 | 8.8 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.7 | 3.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.7 | 34.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.6 | 3.0 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.5 | 5.3 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.5 | 1.8 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.5 | 9.1 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.4 | 2.2 | GO:0033648 | host cell cytoplasm(GO:0030430) host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) host cell cytoplasm part(GO:0033655) tubulin complex(GO:0045298) |
| 0.4 | 6.0 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.4 | 2.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.3 | 3.1 | GO:0034464 | BBSome(GO:0034464) |
| 0.3 | 2.4 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.3 | 25.0 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.3 | 3.0 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.3 | 2.9 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.3 | 4.4 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.3 | 0.9 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) CNTFR-CLCF1 complex(GO:0097059) |
| 0.3 | 3.7 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.2 | 2.2 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.2 | 4.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.2 | 2.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.2 | 1.6 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.2 | 2.0 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.2 | 9.0 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
| 0.2 | 11.4 | GO:0005844 | polysome(GO:0005844) |
| 0.2 | 15.8 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.2 | 2.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.2 | 2.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.2 | 11.1 | GO:0015030 | Cajal body(GO:0015030) |
| 0.1 | 3.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 11.2 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.1 | 1.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.1 | 2.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.1 | 14.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.1 | 3.6 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.1 | 3.8 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.1 | 1.6 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.1 | 0.8 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
| 0.1 | 4.4 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
| 0.1 | 1.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.1 | 11.2 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.1 | 2.5 | GO:0045095 | keratin filament(GO:0045095) |
| 0.1 | 4.7 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.1 | 2.9 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.0 | 5.7 | GO:0031514 | motile cilium(GO:0031514) |
| 0.0 | 0.6 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.0 | 9.2 | GO:0005770 | late endosome(GO:0005770) |
| 0.0 | 2.2 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 1.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.0 | 2.9 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.0 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.0 | 3.0 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.0 | 5.7 | GO:0010008 | endosome membrane(GO:0010008) |
| 0.0 | 2.1 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.0 | 6.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.0 | 2.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.0 | 6.9 | GO:0005769 | early endosome(GO:0005769) |
| 0.0 | 11.8 | GO:0009986 | cell surface(GO:0009986) |
| 0.0 | 0.0 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 0.0 | 1.0 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.0 | 1.4 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.0 | 1.3 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.0 | 1.9 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 3.5 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
| 0.0 | 1.5 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.9 | 8.8 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 2.1 | 6.4 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
| 2.1 | 6.3 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 1.7 | 5.1 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 1.6 | 6.6 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 1.6 | 4.7 | GO:0001861 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
| 1.5 | 8.7 | GO:0003796 | lysozyme activity(GO:0003796) |
| 1.4 | 5.7 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 1.4 | 16.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 1.2 | 6.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 1.2 | 16.7 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 1.1 | 4.6 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 1.0 | 3.8 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 0.9 | 13.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.9 | 3.6 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.8 | 4.0 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.8 | 7.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.8 | 3.1 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.8 | 8.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.7 | 8.9 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.7 | 2.9 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
| 0.6 | 2.6 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.6 | 34.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.6 | 3.6 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
| 0.6 | 2.9 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 0.6 | 28.0 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.6 | 2.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.6 | 97.9 | GO:0003823 | antigen binding(GO:0003823) |
| 0.5 | 2.8 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
| 0.5 | 2.8 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.4 | 3.0 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.4 | 1.6 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
| 0.4 | 2.4 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.4 | 2.8 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.4 | 7.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.4 | 3.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.4 | 1.5 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 0.4 | 12.7 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.3 | 1.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.3 | 5.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.3 | 5.0 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.3 | 1.2 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.3 | 5.5 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 0.3 | 1.5 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.3 | 10.3 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.3 | 7.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.3 | 9.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.3 | 4.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.3 | 4.8 | GO:0017127 | cholesterol transporter activity(GO:0017127) bile acid binding(GO:0032052) |
| 0.3 | 1.4 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.2 | 1.2 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.2 | 5.0 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.2 | 2.1 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.2 | 3.6 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
| 0.2 | 1.8 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.2 | 1.4 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.2 | 4.7 | GO:0005521 | lamin binding(GO:0005521) |
| 0.2 | 0.6 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.2 | 4.0 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.2 | 0.5 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
| 0.1 | 10.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) peptide-lysine-N-acetyltransferase activity(GO:0061733) |
| 0.1 | 3.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.1 | 7.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.1 | 2.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.1 | 0.6 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.1 | 3.0 | GO:0022829 | wide pore channel activity(GO:0022829) |
| 0.1 | 2.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 2.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.1 | 0.7 | GO:0005119 | smoothened binding(GO:0005119) |
| 0.1 | 5.4 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.1 | 0.6 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 1.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.1 | 0.2 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.1 | 1.3 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.1 | 10.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.1 | 3.3 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.1 | 0.6 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.1 | 4.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.1 | 1.9 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.1 | 0.3 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.1 | 17.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.1 | 1.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.1 | 7.3 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
| 0.1 | 2.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.1 | 0.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
| 0.1 | 0.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.1 | 1.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.1 | 4.7 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.1 | 0.6 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 0.1 | 0.8 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.1 | 3.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.1 | 20.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.1 | 18.1 | GO:0003713 | transcription coactivator activity(GO:0003713) |
| 0.0 | 1.1 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.0 | 0.5 | GO:0031432 | titin binding(GO:0031432) |
| 0.0 | 1.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.0 | 4.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.0 | 5.3 | GO:0047485 | protein N-terminus binding(GO:0047485) |
| 0.0 | 0.7 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
| 0.0 | 4.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.0 | 4.2 | GO:0005179 | hormone activity(GO:0005179) |
| 0.0 | 1.5 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.0 | 0.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.0 | 2.2 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.0 | 1.0 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.0 | 1.0 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
| 0.0 | 21.1 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.0 | 0.2 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) BMP receptor binding(GO:0070700) |
| 0.0 | 0.9 | GO:0005319 | lipid transporter activity(GO:0005319) |
| 0.0 | 0.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.0 | 0.5 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.0 | 0.7 | GO:0051117 | ATPase binding(GO:0051117) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.2 | 3.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.2 | 16.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.2 | 3.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.1 | 6.5 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.1 | 2.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.1 | 2.1 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.1 | 1.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.1 | 5.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 5.3 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.1 | 4.4 | PID MYC PATHWAY | C-MYC pathway |
| 0.1 | 6.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.1 | 1.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.1 | 2.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.1 | 1.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.1 | 4.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.1 | 9.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 3.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.1 | 0.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.1 | 3.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.0 | 1.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.0 | 3.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.0 | 2.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.0 | 3.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.0 | 1.1 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.0 | 1.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.0 | 7.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 1.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.0 | 0.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 8.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.8 | 16.7 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.7 | 25.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.4 | 6.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.3 | 2.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.3 | 5.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.3 | 2.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.2 | 5.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.2 | 5.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.2 | 8.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.2 | 16.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.2 | 7.3 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
| 0.2 | 3.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.1 | 6.4 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.1 | 6.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 6.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.1 | 8.7 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.1 | 14.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.1 | 43.6 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.1 | 8.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.1 | 4.9 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.1 | 2.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.1 | 4.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.1 | 3.9 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.1 | 5.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 3.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.1 | 1.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.1 | 1.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.1 | 1.0 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.1 | 1.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.1 | 1.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.0 | 0.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.0 | 1.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.0 | 3.4 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
| 0.0 | 1.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.0 | 0.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.0 | 2.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 0.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |